PA Centers of Excellence

The Center for Adrenal Disorders is a comprehensive clinical care and research initiative formed by the collaborative communities at the Brigham and Women’s Hospital in partnership with the Boston Children’s Hospital, and Dana Farber Cancer Institute, all at Harvard Medical School. The goals of the center are to provide exceptional care for patients with all forms of adrenal disorders, through its expertise and extensive resources, and to improve the understanding, diagnosis, and treatment of adrenal diseases by engaging in collaborative and innovative research. The center offers patients with primary aldosteronism diagnosis, medical management, genetic testing, and surgery.

Cedars-Sinai is a nonprofit academic healthcare organization serving the diverse Los Angeles community and beyond. The organization serves more than 1 million people each year in over 40 locations, with more than 4,500 physicians and nurses and 1,500 research projects in motion. The Hypertension Center in the Smidt Heart Institute of Cedars Sinai is applying a collaborative, multidisciplinary perspective to better diagnosis and treatment of patients with primary aldosteronism. This approach, dubbed “Team Aldo,” pulls together a premier team of experts in the fields of cardiology, endocrinology, interventional radiology and surgery, giving patients access to the kind of comprehensive care that can best address their needs. This comprehensive approach provides confirmatory testing, consultation, and both surgical and nonsurgical treatment options for patients.

Changi General Hospital (CGH) is a public teaching hospital with over 1,000 beds serving a community of more than 1 million people in eastern Singapore. With a wide range of medical specialties and services, it’s helmed by an experienced and skilled team of healthcare professionals who consistently deliver positive health outcomes and care for patients. CGH is a member of the SingHealth cluster of healthcare institutions.

The Endocrinology department is one of the leading centers in Asia for treatment, innovation, and research in primary aldosteronism. The staff’s research on primary aldosteronism and other endocrine diseases has been widely published in leading medical journals and the hospital is the site of multiple clinical trials.

Cleveland Clinic is one of the largest and most respected hospitals in the United States. Their mission is to provide better care of the sick, investigation into their problems, and further education of those who serve. The Endocrinology & Metabolism Institute (EMI) uniquely integrates both the Department of Endocrinology, Diabetes and Metabolism and the Department of Endocrine Surgery. Together, the physicians of EMI direct multidisciplinary centers and programs aimed at improving the care of endocrine conditions, including primary aldosteronism, across the health system.

The mission of the Columbia University Adrenal Center is to provide compassionate and comprehensive care in one location to patients with adrenal disorders. As an integral part of the Columbia University Medical Center, they are able to bring together some of the finest physicians in the world. For each patient, their team of radiologists, endocrinologists, nephrologists, geneticists, cardiologists, and endocrine surgeons work together to plan the optimal course of treatment for the specific disorder and its effects on the rest of the body. Their center is among the few select programs in the U.S. that offer complete multidisciplinary care to adrenal patients. In addition to state-of-the-art diagnostic equipment including PET and MIBG scanners, the center also has a dedicated endovascular facility.

The University of Queensland’s Endocrine Hypertension Research Centre (EHRC) is based at Greenslopes (GH) and Princess Alexandra Hospitals (GAH) in Brisbane. The Centre is a major clinical referral centre for the management of hypertension. Four Hypertension Clinics weekly (three at PAH and one at GH) plus referrals from private rooms provide a sophisticated diagnostic and treatment service for patients from all over Queensland and Northern NSW, with occasional referrals from further afield including Sydney, Melbourne, Tasmania and Asia. Detailed and rigorous inpatient (in demarcated “Hypertension Unit” beds) investigation and treatment protocols are closely supervised by dedicated “Hypertension Unit” nurses. More than 1600 thoroughly studied and documented patients with primary aldosteronism provide a unique resource for further research into causes, diagnosis and treatment, and have led to important collaborations with first-class overseas investigators.